Integer (NYSE:ITGR) posted second-quarter results today that beat the overall consensus forecast on Wall Street. The Plano, Texas–based medical device outsource manufacturer reported profits of $20.8 million, or 62¢ per share, on sales of $350 million for the three months ended July 1, for a bottom-line slide of 29.2% on sales growth of 12.2% compared with […]
Oscor
Integer completes $220M Oscor acquisition
Integer Holdings (NYSE: ITGR) announced today that it has completed its purchase of Oscor — a deal that expands the capabilities of what was already one of the world’s largest medtech contract manufacturers. Integer said the acquisition would cost $220 million when it first announced its plans in October. Get the full story on our […]
Integer beats The Street in Q3, plans to acquire Oscor
Integer Holdings (NYSE:ITGR) posted third-quarter results today that beat the consensus forecast on Wall Street — and announced plans to spend $220 million to acquire Oscor. The Plano, Texas–based medtech contract manufacturing giant plans to finance the acquisition with debt. Integer officials expect the deal to close in December under customary closing conditions. They see […]
Catheter OEM Oscor gets in on $20m Series D for Micro Interventional Devices
Micro Interventional Devices said today that contract manufacturer Oscor led its $20 million Series D round and inked an OEM deal. Newtown, Pa.-based MID said the deal involves a non-exclusive license for Palm Harbor, Fla.-based Oscor’s catheter technology, in return for Oscor’s exclusive right to its MID’s Mia device for treating tricuspid and mitral valve […]
Oscor issues voluntary recall for TB bipolar pacing leads
Oscor is voluntarily recalling a select number of TB temporary bipolar pacing leads with 2mm unshrouded connectors over issues which may expose the connection wire, according to a recently posted FDA alert. The company said that the connector cap housing on the leads may cause the wire to be more susceptible to loss of connectivity […]
5 things medtech manufacturing executives learned from their dads
Sometimes working for your dad seems like destiny, but taking over the family business wasn’t always the plan. There are many second- and third-generation medtech manufacturers run by executives following in their dads’ footsteps. Here’s what they learned. Eric Crainich, president and owner of Design Standards (Charlestown, N.H.), was told from a young age that […]
FDA warns Oscor on process control records
The FDA last month warned contract manufacturer Oscor on its methods for documenting process controls for the catheters and neurostimulation leads it makes, after inspections in February and March turned up a trio of violations. The federal safety watchdog said it inspected Oscor’s plant in Palm Harbor, Fla., where it makes the Adelante Magnum introducer catheter and lead […]
Sorin drops $20M on Oscor’s cardiac lead biz
Sorin Group (BIT:SRN) said it agreed to put $20 million down on Oscor’s cardiac lead manufacturing business as it gears up to develop MRI-safe leads.
Premier strikes CRM deals with Medtronic, Boston Scientific, others
Group purchasing organization Premier Healthcare Alliance struck a deal with 4 major players in the cardiac device market for several cardiac rhythm management device portfolios.
GPO: Novation awards new deals to medtech giants
Group purchasing organization Novation awarded new cardiovascular contracts to a host of market leaders, effective at the beginning of 2013.
